BioElectronics Comments on its U.S. FDA’s OTC Market Clearance Application

FREDERICK, Md., Oct. 10, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced disposable electroceutical devices, announced that on Monday, October 3rd, 2016 it met with senior management from the FDA’s Division of Neurological and Physical Medicine Devices, including the Deputy Division Director, the Acting Branch Chief of the Physical Medicine and […]

BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication

FREDERICK, Md., Sept. 28, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced neuromodulation medical devices announced that it has submitted a paper: “ActiPatch© Central Sensitization Therapy: A Chronic Back Pain Registry Study of Pain Relief & Analgesic Adverse Effects” for publication. The study reports that the majority of chronic back pain sufferers have […]

BioElectronics Launches ActiPatch®, Musculoskeletal Pain Therapy In Sweden

FREDERICK, Md., Sept.13, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Sweden distributor, Harmony Health, Sweden, AB , has received initial stocking orders for Pharmacy Heart,www.apotekhjartat.se and the Life health products chain, www.lifebutiken.se.  Life health products are a chain of 220 stores and Pharmacy […]

BioElectronics Corporation Engages Adam Staelin As Executive Vice President of Sales and Marketing

FREDERICK, Md., May 11, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Adam Staelin as the Executive Vice President of Sales and Marketing. Mr. Staelin has 20 years of sales and marketing experience and has held major management roles at Teradata and Valassis.  While at Teradata, a […]

BioElectronics Responds to U.S. FDA’s Comments on its Market Clearance Application

FREDERICK, Md., May 10, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced that it remains in negotiations with the U.S. Food and Drug Administration (“FDA”) regarding its  510(k) premarket notification for the ActiPatch® Musculoskeletal Pain Therapy. Two weeks ago, it submitted detailed responses to the FDA’s questions related to the […]

BioElectronics’ Drug-free ActiPatch® Pain Therapy Highlighted in UK’s Express Newspaper on Dangers of Excessive Drug Use

FREDERICK, Md., April 28, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its drug-free ActiPatch® product  was noted in the United Kingdom’s Express Newspaper Health Section,  http://www.express.co.uk/life-style/health/664330/arthritis-pain-pills-warning-sufferers-taking-too-many-drugs-fight-agony.  The paper has a circulation of 400,000 that will increase the awareness of ActiPatch therapy for arthritis and chronic pain. The […]

BioElectronics’ ActiPatch® Chronic Pain Therapy Featured In UK’s Leading Daily Mail Newspaper Health Section

BioElectronics’ ActiPatch® Chronic Pain Therapy Featured In UK’s Leading Daily Mail Newspaper Health Section FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its ActiPatch® product’s were featured in the United Kingdom’s leading Daily Mail’s Sunday Health Section, http://www.dailymail.co.uk/health/article-3555221/The-20-pulsing-skin-patch-end-misery-chronic-pain-arthritis-sufferers-diabetics.html. […]

BioElectronics President Interviewed by the StockRadio.com

Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, is pleased to release an interview with President, Andy Whelan. The interview can be heard at http://thestockradio.com/andrew-whelan-bioelectronics-corp-biel-2953.html Mr. Whelan explained the science of bioelectronics, the chronic pain market, the far-reaching […]

BioElectronics Appoints Evomed as Australian and New Zealand Distributor

FREDERICK, MD. March 21, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that it has appointed Evomed (www.evomed.com.au) as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole™ Heel Pain Relief Therapy in Australia and New Zealand. Evomed specializes in the […]

BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget”

FREDERICK, MD. March 15, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen its ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. […]